{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:03:57Z","timestamp":1787169837520,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>The objectives of the study were to determine the clinicodemographic characteristics and the prognostic role of myasthenia gravis (MG) in thymoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      The records of patients who underwent surgical resection of thymoma at King Faisal Specialist Hospital and Research Center in the past 23 years were reviewed. Seventy thymoma patients were finally included and were then categorized based on MG status into the MG group (39 patients) and the non-MG group (31 patients). Collected data included patients\u2019 demographic characteristics, tumor characteristics, and postoperative clinical outcomes. All analyses were conducted using SPSS. The comparison between both groups was tested using the Student\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -test and Chi-square test for continuous and categorical variables, respectively. A\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.05 or less indicated statistical significance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Patients\u2019 age ranged from 11 to 76 years, and female predominance was observed (55.7%). Compared to the non-MG group, no difference in patients\u2019 gender was observed (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.058); however, MG patients had a younger age (39.30 vs. 48.77,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0095). No difference was noted between both groups based on the World Health Organization classification (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.398), but MG patients tended to present with less-advanced tumors based on the TNM classification (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.039) and lower stage based on the MASAOKA staging system (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.017). No significant change in tumor size (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.077), resectability (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.507), and adjuvant therapy (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.075) were observed. MG was not significantly associated with postoperative complications, morbidity, or mortality. However, it exhibited a prognostic protective role in terms of lower recurrence (2.56% vs. 35.48%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.0001) and longer survival duration (18.62 vs. 10.21 years,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) as compared to non-MG patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>MG occurrence in thymoma patients is more likely to occur at a younger age, higher TNM classification, and advanced MASAOKA stage. Although no significant association was noted between MG and complications and mortality, MG exhibited a protective role in thymoma by providing a lower recurrence rate and longer survival duration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/atm.atm_61_23","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T11:12:38Z","timestamp":1697627558000},"page":"211-216","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Clinicodemographic characteristics and prognostic role of myasthenia gravis in thymoma: Experience from a Saudi population"],"prefix":"10.4103","volume":"18","author":[{"given":"Abdullah Al","family":"Shammari","sequence":"first","affiliation":[{"name":"King Faisal Specialist Hospital and Research Center, Alfaisal University, Riyadh, Saudi Arabia"},{"name":"Department of Thoracic Surgery, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Saad","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lama Tareq","family":"Saif","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safy A.","family":"Othman","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad J.","family":"Ghosheh","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghadir M.","family":"Khdeir","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omniyah","family":"Alashgar","sequence":"additional","affiliation":[{"name":"King Faisal Specialist Hospital and Research Center, Alfaisal University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"Abu-Rayya","sequence":"additional","affiliation":[{"name":"King Faisal Specialist Hospital and Research Center, Alfaisal University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Hussein","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Ain Shams University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"AlKattan","sequence":"additional","affiliation":[{"name":"King Faisal Specialist Hospital and Research Center, Alfaisal University, Riyadh, Saudi Arabia"},{"name":"Department of Thoracic Surgery, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Saleh","sequence":"additional","affiliation":[{"name":"King Faisal Specialist Hospital and Research Center, Alfaisal University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,10,17]]},"reference":[{"key":"R1-20240830","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0167-8140(94)01493-M","article-title":"Thymoma: Results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature","volume":"34","author":"Cowen","year":"1995","journal-title":"Radiother Oncol"},{"key":"R2-20240830","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1200\/JCO.2005.04.3133","article-title":"Thymoma associated with keratoconjunctivitis, lichen planus, hypogammaglobinemia, and absent circulating B cells","volume":"24","author":"Hon","year":"2006","journal-title":"J Clin Oncol"},{"key":"R3-20240830","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/00365540500372663","article-title":"Thymoma with immunodeficiency (Good's syndrome): Review of the literature apropos three cases","volume":"38","author":"Miyakis","year":"2006","journal-title":"Scand J Infect Dis"},{"key":"R4-20240830","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/021849230201000213","article-title":"Thymoma associated with pure red-cell aplasia: Clinical features and prognosis","volume":"10","author":"Murakawa","year":"2002","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"R5-20240830","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1468-1331.2006.01476.x","article-title":"Guidelines for the treatment of autoimmune neuromuscular transmission disorders","volume":"13","author":"Skeie","year":"2006","journal-title":"Eur J Neurol"},{"key":"R6-20240830","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ijc.11099","article-title":"Malignant thymoma in the United States: Demographic patterns in incidence and associations with subsequent malignancies","volume":"105","author":"Engels","year":"2003","journal-title":"Int J Cancer"},{"key":"R7-20240830","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/cncr.10665","article-title":"New WHO histologic classification predicts prognosis of thymic epithelial tumors: A clinicopathologic study of 200 thymoma cases from China","volume":"95","author":"Chen","year":"2002","journal-title":"Cancer"},{"key":"R8-20240830","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/cmi.2010.74","article-title":"Thymoma and autoimmunity","volume":"8","author":"Shelly","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"R9-20240830","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N Engl J Med"},{"key":"R10-20240830","first-page":"474512","article-title":"Thymoma in myasthenia gravis: From diagnosis to treatment","author":"Romi","year":"2011","journal-title":"Autoimmune Dis 2011"},{"key":"R11-20240830","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.hoc.2008.03.004","article-title":"Thymoma, myasthenia gravis, and other paraneoplastic syndromes","volume":"22","author":"Tormoehlen","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"key":"R12-20240830","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3988\/jcn.2012.8.3.161","article-title":"Incidence of thymoma in myasthenia gravis: A systematic review","volume":"8","author":"Mao","year":"2012","journal-title":"J Clin Neurol"},{"key":"R13-20240830","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.lungcan.2019.11.007","article-title":"Molecular profiling of thymoma with myasthenia gravis: Risk factors of developing myasthenia gravis in thymoma patients","volume":"139","author":"Lee","year":"2020","journal-title":"Lung Cancer"},{"key":"R14-20240830","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejcts.2010.09.042","article-title":"Thymoma: Inter-relationships among World Health Organization histology, Masaoka staging and myasthenia gravis and their independent prognostic significance: A single-centre experience","volume":"40","author":"Ruffini","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"R15-20240830","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.athoracsur.2004.06.090","article-title":"Thymoma and myasthenia gravis: A clinical study of 1,089 patients from Japan","volume":"79","author":"Kondo","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"R16-20240830","doi-asserted-by":"crossref","first-page":"102337","DOI":"10.1016\/j.jaut.2019.102337","article-title":"Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centers","volume":"106","author":"Lefeuvre","year":"2020","journal-title":"J Autoimmun"},{"key":"R17-20240830","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1177\/02184923221116679","article-title":"Effect of myasthenia gravis on the surgical outcomes of patients with thymoma","volume":"30","author":"Miura","year":"2022","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"R18-20240830","doi-asserted-by":"crossref","first-page":"583489","DOI":"10.3389\/fonc.2020.583489","article-title":"Myasthenia gravis is not an independent prognostic factor of thymoma: Results of a propensity score matching trial of 470 patients","volume":"10","author":"Zhai","year":"2020","journal-title":"Front Oncol"},{"key":"R19-20240830","doi-asserted-by":"crossref","first-page":"711","DOI":"10.21037\/jtd.2016.02.07","article-title":"Postoperative survival for patients with thymoma complicating myasthenia gravis-preliminary retrospective results of the ChART database","volume":"8","author":"Wang","year":"2016","journal-title":"J Thorac Dis"},{"key":"R20-20240830","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0022-5223(97)70399-4","article-title":"Recurrence of thymoma: Analysis of clinicopathologic features, treatment, and outcome","volume":"113","author":"Ruffini","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R21-20240830","doi-asserted-by":"crossref","first-page":"12273","DOI":"10.18632\/oncotarget.24315","article-title":"Thymoma size significantly affects the survival, metastasis and effectiveness of adjuvant therapies: A population based study","volume":"9","author":"Bian","year":"2018","journal-title":"Oncotarget"},{"key":"R22-20240830","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/JTO.0b013e3181a4b8e0","article-title":"The management of thymoma: A systematic review and practice guideline","volume":"4","author":"Falkson","year":"2009","journal-title":"J Thorac Oncol"},{"key":"R23-20240830","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/1097-0142(197601)37:1<229::AID-CNCR2820370133>3.0.CO;2-2","article-title":"Thymoma: A clinical and pathological study of 65 cases","volume":"37","author":"Salyer","year":"1976","journal-title":"Cancer"},{"issue":"Suppl 1","key":"R24-20240830","first-page":"C115","article-title":"Risk factors for developing postthymectomy myasthenic crisis in thymoma patients","volume":"11","author":"Wu","year":"2015","journal-title":"J Cancer Res Ther"},{"key":"R25-20240830","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1046\/j.1468-1331.2003.00678.x","article-title":"Disease severity and outcome in thymoma myasthenia gravis: A long-term observation study","volume":"10","author":"Romi","year":"2003","journal-title":"Eur J Neurol"}],"container-title":["Annals of Thoracic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/atm.atm_61_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:13:55Z","timestamp":1787166835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/atm.atm_61_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/atm.atm_61_23","relation":{},"ISSN":["1817-1737","1998-3557"],"issn-type":[{"value":"1817-1737","type":"print"},{"value":"1998-3557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"2023-02-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}